ONCONETIX INC
ONCO · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $0.58
- Today’s Low
- $0.53
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.59
- Previous Close
- $0.59
- Volume
- 789.45K
- Market Cap
- $3.09M
- P/E Ratio
- --
- EPS
- $-200.08
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 201 EAST FIFTH STREET, CINCINNATI, OH, UNITED STATES, 45202
- Country
- US
- Listing Date
- 2022-02-18
- Fiscal Year End
- December
- Shares Outstanding
- 3.95M
- CIK
- 0001782107
- Website
- www.onconetix.com
Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions. Utilizing a proprietary technology platform, the company specializes in early detection and personalized treatment for a range of malignancies, addressing key unmet needs in the oncology space. With a strong and diverse product pipeline, Onconetix is well-positioned to capitalize on the increasing demand for effective cancer therapies, aiming to significantly improve patient outcomes through its advanced research and development efforts in this dynamic and rapidly advancing field.
Financial Metrics
Revenue
2026-06-30
$17.12K
2026-03-31
$21.45K
2025-12-31
$303.59K
2025-09-30
$303.65K
Operating Expenses
2026-06-30
$2.73M
2026-03-31
$2.09M
2025-12-31
$1.52M
2025-09-30
$2.33M
Net Income
2026-06-30
-$2.86M
2026-03-31
-$4.21M
2025-12-31
$5.66M
2025-09-30
-$8.78M
Net Profit Margin
2026-06-30
-16.74K%
2026-03-31
-19.64K%
2025-12-31
1.86K%
2025-09-30
-2.89K%
Earnings Per Share
2026-06-30
$-1.28
2026-03-31
$0.00
2025-12-31
$0.00
2025-09-30
$-6.25
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.86M
2026-03-31
-$4.2M
2025-12-31
$5.67M
2025-09-30
-$8.48M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
0%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $17.12K | $21.45K | $303.59K | $303.65K |
| Operating Expenses | $2.73M | $2.09M | $1.52M | $2.33M |
| Net Income | -$2.86M | -$4.21M | $5.66M | -$8.78M |
| Net Profit Margin | -16.74K% | -19.64K% | 1.86K% | -2.89K% |
| Earnings Per Share | $-1.28 | $0.00 | $0.00 | $-6.25 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.86M | -$4.2M | $5.67M | -$8.48M |
| Effective Tax Rate | -- | -- | 0% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.